<DOC>
	<DOCNO>NCT01146886</DOCNO>
	<brief_summary>The purpose study investigate safety , tolerability , pharmacokinetics incl . dose proportionality , pharmacodynamics BI 135585 XX ( Part 1 ) , well relative bioavailability two different immediate release tablet formulation versus oral solution ( Part 2 )</brief_summary>
	<brief_title>Trial Investigate Safety , Tolerability , Pharmacokinetics Pharmacodynamics Single Oral Doses BI135585 XX Administered Tablet Solution Healthy Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<criteria>Inclusion criterion : healthy male volunteer</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>October 2013</verification_date>
</DOC>